Basic HTML Version
Trusted, Simple, Safe
1
Reference:
1. IMS MIDAS WorldWide Data - June 2010
Proprietary Name:
Levemir
®
.
Scheduling Status:
S3
Composition:
Insulin detemir 100 units /ml.
Indication:
Treatment of insulin requiring patients with diabetes mellitus.
Registration Number:
38/21.1/0084. For full prescribing information refer to package insert approved by the medicines regulatory authority.
Proprietary Name:
NovoMix
®
30.
Scheduling Status:
S3
Composition:
soluble insulin aspart/protamine crystallised insulin aspart 100 units/ml in the ratio of 30/70.
Indication:
Treatment of insulin
requiring patients with diabetes mellitus.
Registration Number:
35/21.1/0031. For full prescribing information refer to package insert approved by the medicines regulatory authority.
Proprietary Name:
NovoRapid
®
.
Scheduling Status:
S3
Composition:
100 units insulin aspart/ml.
Indication:
Treatment of insulin requiring patients with diabetes mellitus.
Registration Number:
34/21.1/0160. For full prescribing information refer to package insert approved by the medicines regulatory authority.
Novo Nordisk (Pty) Ltd. Reg. No.: 1959/000833/07. PO Box 783155, Sandton, 2146. Tel: (011) 202 0500 Fax: (011) 807 7989 www.novonordisk.co.za NN/DUO/3582/08/10/ver2